← 返回

中国淋巴瘤协作组数据库中早期结外鼻型自然杀伤/T 细胞淋巴瘤初次治疗后远处转移的特征与预后

英文原题:Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.

查看英文原题

Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.

PubMed 2022/11/25(内容时间) EJHaem Q4 · IF 1.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

本研究旨在探讨早期结外鼻型自然杀伤(NK)/T细胞淋巴瘤(ENKTCL)初治后远处转移(DM)的特征及预后。回顾性分析了中国淋巴瘤协作组数据库中1619例患者。采用Fine和Gray竞争风险分析评估DM的累积发生率。使用phi系数评估DM部位之间的相关性,并采用层次聚类对DM部位进行分类。采用回归分析评估无DM生存(DMFS)与总生存期(OS)之间的线性相关性。5年累积DM率为26.2%,年危险率最高出现在第一年(14.9%)。最常见的DM部位为皮肤和软组织(SSTs,32.4%)及远处淋巴结(LNs,31.3%)。DM部位被分为四个预后不同的亚组——远处LN、SST、皮肤外部位和淋巴瘤相关噬血细胞性淋巴组织细胞增生症。SST或远处LN、孤立性转移和晚发性DM表现出相对较好的预后。当代化疗显著降低了DM率并改善了DMFS。DM率的降低进一步与OS概率的增加相关。

我们的研究结果基于四个不同的DM部位增进了对早期ENKTCL多变临床行为的理解,从而为未来的治疗决策、转移监测和转化试验设计提供指导。

展开英文摘要原文

This study aimed to investigate the characteristics and prognosis of distant metastasis (DM) after primary treatment for early-stage extranodal nasal-type natural killer (NK)/T-cell lymphoma (ENKTCL). A total of 1619 patients from the China Lymphoma Collaborative Group database were retrospectively reviewed. The cumulative incidence of DM was assessed using Fine and Gray's competing risk analysis. The correlation between DM sites was evaluated using phi coefficients, while DM sites were classified using hierarchical clustering. Regression analysis was used to assess the linear correlation between DM-free survival (DMFS) and overall survival (OS).

The 5-year cumulative DM rate was 26. 2%, with the highest annual hazard rate being in the first year (14. 9%). The most frequent DM sites were the skin and soft tissues (SSTs, 32. 4%) and distant lymph nodes (LNs, 31. 3%). DM sites were categorized into four subgroups of distinct prognosis - distant LN, SST, extracutaneous site, and lymphoma-associated hemophagocytic lymphohistiocytosis.

SST or distant LN, solitary metastasis, and late-onset DM demonstrated a relatively favorable prognosis. Contemporary chemotherapy significantly decreased DM rates and improved DMFS. Decreased DM rates were further associated with increased OS probabilities.

Our findings improve the understanding of the variable clinical behaviors of early-stage ENKTCL based on four distinct DM sites and thus provide guidance for future therapeutic decisions, metastatic surveillance, and translational trial design.

论文信息

作者
Zheng X、Qu BL、Liu X、Zhong QZ、Qian LT、Yang Y、Hou XR、Qiao XY
单位
Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.China
期刊
EJHaem2023 Feb
原文标识
PubMed 36819187 · DOI 10.1002/jha2.613